The genomic landscape of CYP2D6 variation in the Indian population

被引:0
|
作者
Sivadas, Ambily [1 ]
Rathore, Surabhi [2 ,3 ]
Sahana, S. [2 ,3 ]
Jolly, Bani [2 ,3 ]
Bhoyar, Rahul C. [2 ]
Jain, Abhinav [2 ,3 ]
Sharma, Disha [2 ]
Imran, Mohamed [2 ,3 ]
Senthilvel, Vigneshwar [2 ,3 ]
Divakar, Mohit Kumar [2 ,3 ]
Mishra, Anushree [2 ,3 ]
Sivasubbu, Sridhar [2 ,3 ,4 ]
Scaria, Vinod [2 ,3 ,4 ]
机构
[1] St Johns Natl Acad Hlth Sci, Div Nutr, St Johns Res Inst, Bangalore 560034, Karnataka, India
[2] CSIR, Inst Genom & Integrat Biol, Mathura Rd, New Delhi 110025, India
[3] Acad Sci & Innovat Res AcSIR, Ghaziabad 201002, Uttar Pradesh, India
[4] Vishwanath Canc Care Fdn, B 702,7th Floor,Neelkanth Business Pk Kirol Villag, Vidya Vihar 400086, West Mumbai, India
关键词
cytochrome P450; drug metabolism; genomics; Indian population; molecular dynamics simulation; personalized medicine; pharmacogenomics; pharmacology; polymorphism; DRUG-METABOLIZING-ENZYMES; GENETIC-POLYMORPHISM; POOR METABOLIZERS; CRYSTAL-STRUCTURE; IN-SILICO; WILD-TYPE; DEBRISOQUINE; VARIANTS; IDENTIFICATION; FREQUENCY;
D O I
10.2217/pgs-2023-0233
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aim: The CYP2D6 gene is highly polymorphic, causing large interindividual variability in the metabolism of several clinically important drugs. Materials & methods: The authors investigated the diversity and distribution of CYP2D6 alleles in Indians using whole genome sequences (N = 1518). Functional consequences were assessed using pathogenicity scores and molecular dynamics simulations. Results: The analysis revealed population-specific CYP2D6 alleles (*86, *7, *111, *112, *113, *99) and remarkable differences in variant and phenotype frequencies with global populations. The authors observed that one in three Indians could benefit from a dose alteration for psychiatric drugs with accurate CYP2D6 phenotyping. Molecular dynamics simulations revealed large conformational fluctuations, confirming the predicted reduced function of *86 and *113 alleles. Conclusion: The findings emphasize the utility of comprehensive CYP2D6 profiling for aiding precision public health.
引用
收藏
页码:147 / 160
页数:14
相关论文
共 50 条
  • [41] Genetic polymorphism of CYP2D6 in Korean population.
    Jung, HJ
    Kim, MK
    Yoon, YR
    Park, JY
    Shin, JG
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (02) : P38 - P38
  • [42] Genotype and allele frequency of CYP2D6 in Tamilian population
    C. Adithan
    N. Gerard
    A. T. Naveen
    K. Koumaravelou
    C. H. Shashindran
    R. Krishnamoorthy
    European Journal of Clinical Pharmacology, 2003, 59 : 517 - 520
  • [43] Genetic polymorphisms analysis of CYP2D6 in the Uygur population
    He, Xue
    He, Na
    Ren, Lisong
    Ouyang, Yongri
    Zhang, Ning
    Ma, Yini
    Yuan, Dongya
    Kang, Longli
    Jin, Tianbo
    BMC GENOMICS, 2016, 17
  • [44] CYP2D6 copy number distribution in the US population
    Beoris, Michelle
    Wilson, Jean Amos
    Garces, Jorge A.
    Lukowiak, Andrew A.
    PHARMACOGENETICS AND GENOMICS, 2016, 26 (02): : 96 - 99
  • [45] Evaluation of CYP2D6 phenotype in the Yoruba Nigerian population
    Adedeji, Waheed Adeola
    Igbinoba, Sharon Iyobor
    Fakeye, Titilayo O.
    Oladosu, Ibrahim Adebayo
    Fehintola, Fatai Adewale
    Ma, Qing
    Morse, Gene D.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2017, 10 (10) : 1145 - 1152
  • [46] Distribution of CYP2D6 Alleles and Phenotypes in the Brazilian Population
    Friedrich, Deise C.
    Genro, Julia P.
    Sortica, Vinicius A.
    Suarez-Kurtz, Guilherme
    de Moraes, Maria Elizabete
    Pena, Sergio D. J.
    Ribeiro dos Santos, Andrea K.
    Romano-Silva, Marco A.
    Hutz, Mara H.
    PLOS ONE, 2014, 9 (10):
  • [47] Genetic polymorphisms analysis of CYP2D6 in the Uygur population
    Xue He
    Na He
    Lisong Ren
    Yongri Ouyang
    Ning Zhang
    Yini Ma
    Dongya Yuan
    Longli Kang
    Tianbo Jin
    BMC Genomics, 17
  • [48] Genotype and allele frequency of CYP2D6 in Tamilian population
    Adithan, C
    Gerard, N
    Naveen, AT
    Koumaravelou, K
    Shashindran, CH
    Krishnamoorthy, R
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 59 (07) : 517 - 520
  • [49] The Impact of the CYP2D6 "Enhancer" Single Nucleotide Polymorphism on CYP2D6 Activity
    Dinh, Jean C.
    Boone, Erin C.
    Staggs, Vincent S.
    Pearce, Robin E.
    Wang, Wendy Y.
    Gaedigk, Roger
    Leeder, James Steven
    Gaedigk, Andrea
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 (03) : 646 - 654
  • [50] Allele Drop Out Conferred by a Frequent CYP2D6 Genetic Variation For Commonly Used CYP2D6*3 Genotyping Assays
    Scantamburlo, Giada
    Tziolia, Konstantina
    Zopf, Michaela
    Bernardinelli, Emanuele
    Soyal, Selma M.
    Civello, Davide Antonio
    Vanoni, Simone
    Dossena, Silvia
    Patsch, Wolfgang
    Patrinos, George P.
    Paulmichl, Markus
    Nofziger, Charity
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2017, 43 (06) : 2297 - 2309